Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser and Tazarotene for Nail Psoriasis
NCT03263624Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Oct 2017
- Primary completion
- Oct 2018
01
Overview
Phase 4, randomised, single-blind trial (2 arms), sponsored by Assiut University. Primary endpoints: Percentage of clinically improved patients using modified Nail Psoriasis Severity Index at 3 months and Modified Nail Psoriasis Severity Index Score at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT03263624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263624.